Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic evolution of human respiratory syncytial virus during a decade (2013–2023): bridging the path to monoclonal antibody surveillance
María Piñana, Alejandra González-Sánchez, Cristina Andrés, et al.
Journal of Infection (2024) Vol. 88, Iss. 5, pp. 106153-106153
Open Access | Times Cited: 10

Showing 10 citing articles:

The recent landscape of RSV vaccine research
Karen Kelleher, N. Subramaniam, Simon B. Drysdale
Therapeutic Advances in Vaccines and Immunotherapy (2025) Vol. 13
Open Access | Times Cited: 3
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
Heidi L Moline, Ariana P. Toepfer, Ayzsa Tannis, et al.
JAMA Pediatrics (2024)
Closed Access | Times Cited: 7
Molecular epidemiology and phylogenetic analysis of human respiratory syncytial virus type B in Riyadh, Saudi Arabia
Reem M. Aljowaie, Mohamed A. Farrag, Tarad Abalkhail, et al.
Virus Genes (2025)
Closed Access
Microevolution and phylogenomic study of Respiratory Syncytial Virus type A
Ashfaq Ahmad, Sidra Majaz, Aamir Saeed, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319437-e0319437
Open Access
Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic
Alan M. Rice, Gabriel González, Michael J. Carr, et al.
Microbial Genomics (2025) Vol. 11, Iss. 3
Open Access
Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024
Nadia Martínez-Marrero, Juan Carlos Muñoz-Escalante, Rosa María Wong‐Chew, et al.
Viruses (2025) Vol. 17, Iss. 5, pp. 651-651
Open Access
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue
Qianqian Li, Huan Li, Zhihua Li, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 2
Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022
Mariana Haeberer, Martin Mengel, Rong Fan, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2395-2413
Open Access | Times Cited: 1
Landscape of respiratory syncytial virus
Yuping Duan, Zimeng Liu, Na Zang, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 24, pp. 2953-2978
Open Access | Times Cited: 1
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1317-1317
Open Access
Page 1

Scroll to top